Literature DB >> 21945804

miRNA Expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132.

Eva M Jimenez-Mateos1, Isabella Bray, Amaya Sanz-Rodriguez, Tobias Engel, Ross C McKiernan, Genshin Mouri, Katsuhiro Tanaka, Takanori Sano, Julie A Saugstad, Roger P Simon, Raymond L Stallings, David C Henshall.   

Abstract

When an otherwise harmful insult to the brain is preceded by a brief, noninjurious stimulus, the brain becomes tolerant, and the resulting damage is reduced. Epileptic tolerance develops when brief seizures precede an episode of prolonged seizures (status epilepticus). MicroRNAs (miRNAs) are small, noncoding RNAs that function as post-transcriptional regulators of gene expression. We investigated how prior seizure preconditioning affects the miRNA response to status epilepticus evoked by intra-amygdalar kainic acid in mice. The miRNA was extracted from the ipsilateral CA3 subfield 24 hours after focal-onset status epilepticus in animals that had previously received either seizure preconditioning (tolerance) or no preconditioning (injury), and mature miRNA levels were measured using TaqMan low-density arrays. Expression of 21 miRNAs was increased, relative to control, after status epilepticus alone, and expression of 12 miRNAs was decreased. Increased miR-132 levels were matched with increased binding to Argonaute-2, a constituent of the RNA-induced silencing complex. In tolerant animals, expression responses of >40% of the injury-group-detected miRNAs differed, being either unchanged relative to control or down-regulated, and this included miR-132. In vivo microinjection of locked nucleic acid-modified oligonucleotides (antagomirs) against miR-132 depleted hippocampal miR-132 levels and reduced seizure-induced neuronal death. Thus, our data strongly suggest that miRNAs are important regulators of seizure-induced neuronal death.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21945804      PMCID: PMC3204080          DOI: 10.1016/j.ajpath.2011.07.036

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  60 in total

Review 1.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

2.  microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus.

Authors:  Stephen T Magill; Xiaolu A Cambronne; Bryan W Luikart; Daniel T Lioy; Barbara H Leighton; Gary L Westbrook; Gail Mandel; Richard H Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

3.  MicroRNAs induced during ischemic preconditioning.

Authors:  Soon-Tae Lee; Kon Chu; Keun-Hwa Jung; Hye-Jin Yoon; Daejong Jeon; Kyoung-Mook Kang; Ki-Ho Park; Eun-Kee Bae; Manho Kim; Sang Kun Lee; Jae-Kyu Roh
Journal:  Stroke       Date:  2010-06-24       Impact factor: 7.914

Review 4.  MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration.

Authors:  Julie A Saugstad
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-07       Impact factor: 6.200

5.  Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex.

Authors:  Theresa A Lusardi; Carol D Farr; Craig L Faulkner; Giuseppe Pignataro; Tao Yang; Jingquan Lan; Roger P Simon; Julie A Saugstad
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-16       Impact factor: 6.200

6.  Recombinant Adeno-Associated Virus-Mediated microRNA Delivery into the Postnatal Mouse Brain Reveals a Role for miR-134 in Dendritogenesis in Vivo.

Authors:  Mette Christensen; Lars A Larsen; Sakari Kauppinen; Gerhard Schratt
Journal:  Front Neural Circuits       Date:  2010-01-12       Impact factor: 3.492

7.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

8.  An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP.

Authors:  Gary A Wayman; Monika Davare; Hideaki Ando; Dale Fortin; Olga Varlamova; Hai-Ying M Cheng; Daniel Marks; Karl Obrietan; Thomas R Soderling; Richard H Goodman; Soren Impey
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-24       Impact factor: 11.205

9.  A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis.

Authors:  Gabriele Siegel; Gregor Obernosterer; Roberto Fiore; Martin Oehmen; Silvia Bicker; Mette Christensen; Sharof Khudayberdiev; Philipp F Leuschner; Clara J L Busch; Christina Kane; Katja Hübel; Frank Dekker; Christian Hedberg; Balamurugan Rengarajan; Carsten Drepper; Herbert Waldmann; Sakari Kauppinen; Michael E Greenberg; Andreas Draguhn; Marc Rehmsmeier; Javier Martinez; Gerhard M Schratt
Journal:  Nat Cell Biol       Date:  2009-05-24       Impact factor: 28.824

10.  Specificity, duplex degradation and subcellular localization of antagomirs.

Authors:  Jan Krützfeldt; Satoru Kuwajima; Ravi Braich; Kallanthottathil G Rajeev; John Pena; Thomas Tuschl; Muthiah Manoharan; Markus Stoffel
Journal:  Nucleic Acids Res       Date:  2007-04-16       Impact factor: 16.971

View more
  100 in total

1.  MiR-219 Protects Against Seizure in the Kainic Acid Model of Epilepsy.

Authors:  Honghua Zheng; Rong Tang; Yi Yao; Zhilin Ji; Yuanyuan Cao; Zhaoji Liu; Feng Peng; Wenjie Wang; Dan Can; Huiqin Xing; Guojun Bu; Huaxi Xu; Yun-Wu Zhang; Weihong Zheng
Journal:  Mol Neurobiol       Date:  2014-11-15       Impact factor: 5.590

2.  Expression profiling the microRNA response to epileptic preconditioning identifies miR-184 as a modulator of seizure-induced neuronal death.

Authors:  Ross C McKiernan; Eva M Jimenez-Mateos; Takanori Sano; Isabella Bray; Raymond L Stallings; Roger P Simon; David C Henshall
Journal:  Exp Neurol       Date:  2012-07-05       Impact factor: 5.330

Review 3.  Epigenetic mechanisms in stroke and epilepsy.

Authors:  Jee-Yeon Hwang; Kelly A Aromolaran; R Suzanne Zukin
Journal:  Neuropsychopharmacology       Date:  2012-08-15       Impact factor: 7.853

4.  Inhibition of miR-203 Reduces Spontaneous Recurrent Seizures in Mice.

Authors:  Soon-Tae Lee; Daejong Jeon; Kon Chu; Keun-Hwa Jung; Jangsup Moon; Junsang Sunwoo; Dong-Kyu Park; Hyunwoo Yang; Ji-Hyun Park; Manho Kim; Jae-Kyu Roh; Sang Kun Lee
Journal:  Mol Neurobiol       Date:  2016-05-10       Impact factor: 5.590

Review 5.  MicroRNA and epilepsy: profiling, functions and potential clinical applications.

Authors:  David C Henshall
Journal:  Curr Opin Neurol       Date:  2014-04       Impact factor: 5.710

Review 6.  Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents.

Authors:  Xiaohuan Xia; Yi Wang; Yunlong Huang; Han Zhang; Hongfang Lu; Jialin C Zheng
Journal:  Prog Neurobiol       Date:  2019-09-19       Impact factor: 11.685

7.  Correlation of MicroRNA 132 Up-regulation with an Unfavorable Clinical Outcome in Patients with Primary Glioblastoma Multiforme Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide Chemotherapy.

Authors:  Nicole R Parker; Nelson Correia; Brendan Crossley; Michael E Buckland; Viive M Howell; Helen R Wheeler
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

Review 8.  Sex, epilepsy, and epigenetics.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Neurobiol Dis       Date:  2014-07-04       Impact factor: 5.996

9.  Expression of p-CREB and activity-dependent miR-132 in temporal lobe epilepsy.

Authors:  Jing Guo; Heng Wang; Qian Wang; Yangmei Chen; Shengli Chen
Journal:  Int J Clin Exp Med       Date:  2014-05-15

Review 10.  MicroRNA-induced silencing in epilepsy: Opportunities and challenges for clinical application.

Authors:  Durgesh Tiwari; Katrina Peariso; Christina Gross
Journal:  Dev Dyn       Date:  2017-10-04       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.